Почетна › Малоклеточен рак на бели дробови › Мичиген
Клинички испитувања за Малоклеточен рак на бели дробови во Мичиген
26 студии за Малоклеточен рак на бели дробови бараат учесници на локации во Мичиген.
Градови во Мичиген
Официјален текст на студијата (англиски)
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Henry Ford Hospital - Detroit /ID# 277218, Detroit
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07155174177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- BAMF Health, Grand Rapids
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- Veterans Affairs Ann Arbor Healthcare System, Ann Arbor
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07472517A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Corewell Health William Beaum Hosp, Royal Oak
Се регрутираФаза 1
Возраст од 18 до 100 · Сите полови · Ажурирано 22.9.2026 · NCT07006727A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Barbara Ann Karmanos Cancer Center, Detroit
- START Midwest, Grand Rapids
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07488676Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
Се регрутираФаза 3
Возраст од 18 до 99 · Сите полови · Ажурирано 17.9.2026 · NCT07778316A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
- Karmanos Cancer Institute, Detroit
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07325136A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Henry Ford Health Cancer, Detroit
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07218146Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
- Henry Ford Cancer Institute, Detroit
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 19.8.2026 · NCT06922539A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT06242470A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT05592626A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Henry Ford Health System, Detroit
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 6.8.2026 · NCT06203210Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
- Henry Ford Cancer- Detroit, Detroit
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 28.7.2026 · NCT07339059A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- START Midwest, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT06131840A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- START Midwest, Grand Rapids
- The Cancer and Hematology Centers, Grand Rapids
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 9.7.2026 · NCT07174583Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
- Trinity Health Saint Joseph Mercy Ann Arbor, Ann Arbor
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 26.6.2026 · NCT06598306AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
- START Midwest, Grand Rapids
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.6.2026 · NCT07454642MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Karmanos Cancer Center (Wayne State University), Detroit
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 29.4.2026 · NCT05903092Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- и уште 14
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 30.3.2026 · NCT06769126Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 11.3.2026 · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- START Midwest, Grand Rapids
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 18.2.2026 · NCT07030257JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
- Henry Ford Health System, Detroit
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 9.1.2026 · NCT05490472A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 21.11.2025 · NCT05914116Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
- V.A. Ann Arbor Healthcare System, Ann Arbor
- University of Michigan, Ann Arbor
Се регрутираФаза 2
Сите возрасти · Сите полови · Ажурирано 17.11.2025 · NCT05588388A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- University of Michigan Hospitals, Ann Arbor
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2025 · NCT06805825Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.